XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
CURRENT ASSETS:    
Cash and cash equivalents $ 311,399 $ 326,184
Marketable securities 7,497 7,526
Research and development tax credits receivable 2,263 2,011
Other receivables 3,169 4,153
Prepaid expenses 3,882 6,678
Total current assets 328,210 346,552
Property and equipment, net 4,466 3,948
Restricted cash 215 212
Operating lease right-of-use assets 4,303 4,674
Other assets 288 288
Deferred tax assets 1,586 1,412
TOTAL ASSETS 339,068 357,086
CURRENT LIABILITIES:    
Accounts payable 3,352 2,251
Accrued expenses and other current liabilities 6,389 5,975
Operating lease liability, current portion 568 697
Deferred revenue, current portion 2,081 2,073
Income tax payable 30 18
Total current liabilities 12,420 11,014
Operating lease liability, net of current portion 3,235 3,308
Deferred revenue, net of current portion 55,760 55,934
TOTAL LIABILITIES 71,415 70,256
SHAREHOLDERS’ EQUITY    
Preferred shares, no par value per share; unlimited shares authorized as of March 31, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively
Common shares, no par value per share; unlimited shares authorized as of March 31, 2021 and December 31, 2020; 36,990,710 and 36,902,924 shares issued and outstanding as of March 31, 2021, and December 31, 2020, respectively 384,610 384,313
Additional paid-in capital 7,818 5,875
Accumulated deficit (124,775) (103,358)
Total shareholders’ equity 267,653 286,830
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 339,068 $ 357,086